Director Jonathan Schechter made three open market purchases of TaoWeave Inc. ($TWAV) shares in the last year, totaling nearly $60,000, with the most recent on November 14, 2025. These rank 2,816th among insiders in our database. He also bought PharmaCyte Biotech Inc. ($PMCB) shares three times for about $48,000, most recently on January 7, 2026, ranking 3,087th. Among 4,983 insiders averaging $1.5 million per buyer and 3.29 transactions, Schechter had no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | PharmaCyte Biotech, Inc. | $PMCB | SCHECHTER JONATHAN | Director | A | Stock Option (Right to Buy) | 119170 | $0.00 | 119,170.0000 | 10,134,160 | 9999.99% | 1.18% |
| Jan. 7, 2026 | PharmaCyte Biotech, Inc. | $PMCB | SCHECHTER JONATHAN | Director | P | Common Stock | 20000 | $0.84 | 192,500.0000 | 10,134,160 | 11.59% | 0.20% |
| Jan. 6, 2026 | PharmaCyte Biotech, Inc. | $PMCB | SCHECHTER JONATHAN | Director | P | Common Stock | 20000 | $0.79 | 172,500.0000 | 10,134,160 | 13.11% | 0.20% |
| Jan. 5, 2026 | PharmaCyte Biotech, Inc. | $PMCB | SCHECHTER JONATHAN | Director | P | Common Stock | 20000 | $0.78 | 152,500.0000 | 10,134,160 | 15.09% | 0.20% |
| Dec. 12, 2025 | PharmaCyte Biotech, Inc. | $PMCB | SCHECHTER JONATHAN | Director | F | Common Stock | 67500 | $1.02 | 132,500.0000 | 6,795,779 | 33.75% | 0.99% |
| April 25, 2025 | PharmaCyte Biotech, Inc. | $PMCB | SCHECHTER JONATHAN | Director | A | Stock Option (Right to Buy) | 63233 | $0.00 | 63,233.0000 | 0 | 9999.99% | 0.00% |
| Dec. 12, 2025 | PharmaCyte Biotech, Inc. | $PMCB | SCHECHTER JONATHAN | Director | A | Common Stock | 150000 | $0.00 | 200,000.0000 | 6,795,779 | 300.00% | 2.21% |
| Nov. 14, 2025 | TaoWeave, Inc. | $TWAV | SCHECHTER JONATHAN | Director | P | COMMON STOCK | 10000 | $1.91 | 25,000.0000 | 3,207,210 | 66.67% | 0.31% |
| Aug. 6, 2025 | TAO Synergies Inc. | $TAOX | SCHECHTER JONATHAN | Director | A | Employee Stock Option (right to buy) | 10000 | $0.00 | 10,000.0000 | 1,565,200 | 9999.99% | 0.64% |
| Sept. 17, 2025 | TaoWeave, Inc. | $TWAV | SCHECHTER JONATHAN | Director | P | COMMON STOCK | 5000 | $2.70 | 15,000.0000 | 1,154,926 | 50.00% | 0.43% |
| Sept. 16, 2025 | TaoWeave, Inc. | $TWAV | SCHECHTER JONATHAN | Director | P | COMMON STOCK | 10000 | $2.73 | 10,000.0000 | 1,154,926 | 9999.99% | 0.87% |
| June 30, 2025 | TAO Synergies Inc. | $TAOX | SCHECHTER JONATHAN | Director | A | Common Stock, par value $0.0001 per share | 21575 | $0.00 | 22,665.0000 | 1,392,881 | 1979.36% | 1.55% |
| June 30, 2025 | TAO Synergies Inc. | $TAOX | SCHECHTER JONATHAN | Director | F | Common Stock, par value $0.0001 per share | 8630 | $7.85 | 14,035.0000 | 1,392,881 | 38.08% | 0.62% |
| April 3, 2025 | TAO Synergies Inc. | $TAOX | SCHECHTER JONATHAN | Director | A | Stock Option (Right to Buy) | 800 | $0.00 | 800.0000 | 1,392,881 | 9999.99% | 0.06% |
| April 30, 2024 | PharmaCyte Biotech, Inc. | $PMCB | SCHECHTER JONATHAN | Director | A | Stock Option (Right to Buy) | 38009 | $0.00 | 38,009.0000 | 0 | 9999.99% | 0.00% |
| April 8, 2024 | TAO Synergies Inc. | $TAOX | SCHECHTER JONATHAN | Director | A | Stock Option (Right to Buy) | 800 | $0.00 | 800.0000 | 1,036,700 | 9999.99% | 0.08% |
| March 29, 2023 | TAO Synergies Inc. | $TAOX | SCHECHTER JONATHAN | Director | A | Stock Option (Right to Buy) | 20000 | $0.00 | 20,000.0000 | 6,989,200 | 9999.99% | 0.29% |